Refine Search

New Search

Result: 1

(searched for: Revisiting a Meta-analysis Shows that Hydroxychloroquine with Azithromycin may be Efficient in Covid-19 patients)
Save to Scifeed
Page of 1
Articles per Page
by
Show export options
  Select all
Valère Lounnas, Alexis Lacout, Xavier Azalbert, Christian Perronne
Archives of Microbiology & Immunology, Volume 5, pp 154-175; doi:10.26502/ami.93650055

Abstract:
Objective: To analyze the impact of study selection on the results of a recently published meta-analysis of the efficacy of hydroxychloroquine (HCQ) and hydroxychloroquine plus azithromycin (AZI) in Covid-19 patients. Methods: 31 studies were reviewed looking for critical bias. Combined hazard ratios and confidence intervals were calculated for both treatments using a fixed effects size model and a random effects model. Quantitative analysis regarding the toxicity of the association HCQ plus AZI is made. Results: Meta-analyses performed on the 11 studies we deem critically unbiased show a mortality reduction of 55% for HCQ and 66% for HCQ plus AZI. For both treatments, our meta-analysis indicates a significant efficacy in reducing mortality in hospitalized Covid-19 patients.
Page of 1
Articles per Page
by
Show export options
  Select all
Back to Top Top